Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in Europe.

J. R. Santos, A. Cozzi-Lepri, A. Phillips, S. De Wit, C. Pedersen, P. Reiss, A. Blaxhult, A. Lazzarin, M. Sluzhynska, C. Orkin, C. Duvivier, J. Bogner, P. Gargalianos-Kakolyris, P. Schmid, G. Hassoun, I. Khromova, M. Beniowski, V. Hadziosmanovic, D. Sedlacek, R. ParedesJ. D. Lundgren, EuroSIDA study group, Mauro Zaccarelli, Andrea Antinori, Maria Maddalena Plazzi, Rosa Antonietta Acinapura

Research output: Contribution to journalArticle

Original languageEnglish
JournalHIV Medicine
DOIs
Publication statusPublished - Feb 1 2018

Cite this

Santos, J. R., Cozzi-Lepri, A., Phillips, A., Wit, S. D., Pedersen, C., Reiss, P., Blaxhult, A., Lazzarin, A., Sluzhynska, M., Orkin, C., Duvivier, C., Bogner, J., Gargalianos-Kakolyris, P., Schmid, P., Hassoun, G., Khromova, I., Beniowski, M., Hadziosmanovic, V., Sedlacek, D., ... Acinapura, R. A. (2018). Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in Europe. HIV Medicine. https://doi.org/10.1111/hiv.12581